VIVESTO AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.285 SEK | -1.55% |
|
-9.52% | -30.06% |
| 03-26 | Transcript : Vivesto AB - Special Call | |
| 03-07 | Vivesto AB Doses First Patient in its Clinical Paccal Vet Trial | CI |
Chart calendar Vivesto AB
b407d3eb61c06174a740ab3e605.etMnjS44dmB1mzerv17eUINmNXyK7zJ3e9oc1CFyDBc.KJgR72JLP1lHtnid2huzJvIWUBjNuUU4K-1-gXQ5Q2A_5GPcbwk0CDvtDw~0d4908e04966c884748dc75bd2c16896
Upcoming events on Vivesto AB
Past events on Vivesto AB
| 21/02/2024 | Q4 2023 Earnings Release |
| 15/11/2023 | Q3 2023 Earnings Release |
| 23/08/2023 | Q2 2023 Earnings Release |
| 25/05/2023 08:00 | Annual General Meeting |
| 25/05/2023 07:00 | Q1 2023 Earnings Release |
| 23/02/2023 07:00 | FY 2022 Earnings Release |
| 17/11/2022 09:00 | Q3 2022 Earnings Call |
| 17/11/2022 07:00 | Q3 2022 Earnings Release |
| 25/08/2022 09:00 | Interim 2022 Earnings Call |
| 25/08/2022 07:00 | Interim 2022 Earnings Release |
| 25/05/2022 09:00 | Q1 2022 Earnings Call |
| 25/05/2022 07:00 | Q1 2022 Earnings Release |
| 24/05/2022 | Annual General Meeting |
| 03/05/2022 | Anglonordic Life Science Conference |
| 22/03/2022 | Vator Swiss Nordic BIO |
| 13/03/2022 | Investor Meeting |
| 28/02/2022 | Sachs Associates European Life Sciences CEO Forum |
| 24/02/2022 09:00 | FY 2021 Earnings Call |
| 24/02/2022 07:00 | FY 2021 Earnings Release |
| 21/02/2022 09:00 | Extraordinary Shareholders Meeting |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 3,17 7,52 -57.86% | 1,98 12,1 -83.64% | 0,00 | 26,2 16,5 58.74% | 1,02 2,00 -49.25% |
|
EBITDA Million SEK | Released Forecast Spread | -98,9 -92,9 -6.51% | -114 -88,4 -28.41% | 0,00 | -99,8 -147 32.31% | -90,5 -91,0 0.52% |
|
EBIT Million SEK | Released Forecast Spread | -104 -97,5 -6.36% | -120 -95,0 -26.46% | 0,00 | -129 -176 26.95% | -165 -164 -0.61% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -118 -112 -5.37% | -138 -113 -22.29% | 0,00 | -133 -179 25.85% | -167 -167 0.19% |
|
Net income Million SEK | Released Forecast Spread | -118 -112 -5.65% | -171 -146 -17.36% | -10,5 | -133 -179 25.85% | -167 -167 0.19% |
|
EPS SEK | Released Forecast Spread | -0,71 -0,69 -3.55% | -0,88 -0,58 -51.39% | -0,03 | -0,30 -0,40 25% | -0,34 -0,31 -9.68% |
| Announcement Date | 08/06/18 | 28/06/19 | 19/08/20 | 24/02/22 | 23/02/23 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 |
|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 11,9 0,20 5860% | 9,64 0,20 4719.5% |
|
EBITDA Million SEK | Released Forecast Spread | -22,3 -30,9 27.87% | 5,21 -33,9 115.36% |
|
EBIT Million SEK | Released Forecast Spread | -29,6 -38,1 22.38% | -2,07 -41,1 94.97% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -31,0 -38,4 19.3% | -2,85 -41,8 93.18% |
|
Net income Million SEK | Released Forecast Spread | -31,0 -38,4 19.3% | -2,85 -41,8 93.18% |
| Announcement Date | 18/11/21 | 24/02/22 |
More events
Past sector events for Vivesto AB
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VIVE Stock
- Calendar Vivesto AB
